{"id":"https://openalex.org/W1978614486","doi":"https://doi.org/10.1016/0014-2999(88)90283-x","title":"Blockade of potentiated startle responding in rats by 5-hydroxytryptamine1A receptor ligands","display_name":"Blockade of potentiated startle responding in rats by 5-hydroxytryptamine1A receptor ligands","alternate_titles":[],"publication_year":1988,"publication_date":"1988-11-01","ids":{"openalex":"https://openalex.org/W1978614486","doi":"https://doi.org/10.1016/0014-2999(88)90283-x","mag":"1978614486","pmid":"https://pubmed.ncbi.nlm.nih.gov/2975225"},"language":"en","primary_location":{"id":"doi:10.1016/0014-2999(88)90283-x","doi":"https://doi.org/10.1016/0014-2999(88)90283-x","is_oa":false,"landing_page_url":"https://doi.org/10.1016/0014-2999(88)90283-x","pdf_url":null,"source":{"id":"https://openalex.org/S187816532","display_name":"European Journal of Pharmacology","issn_l":"0014-2999","issn":["0014-2999","1879-0712"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Journal of Pharmacology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1978614486"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5022528712","display_name":"Robert S. Mansbach","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I36258959","display_name":"University of California San Diego","ror":"https://ror.org/0168r3w48","country_code":"US","type":"education","lineage":["https://openalex.org/I36258959"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Robert S. Mansbach","raw_affiliation_strings":["Department of Psychiatry, University of California at San Diego, La Jolla 92093"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Psychiatry, University of California at San Diego, La Jolla 92093","institution_ids":["https://openalex.org/I36258959"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5109240885","display_name":"Mark A. Geyer","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I36258959","display_name":"University of California San Diego","ror":"https://ror.org/0168r3w48","country_code":"US","type":"education","lineage":["https://openalex.org/I36258959"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mark A. Geyer","raw_affiliation_strings":["Department of Psychiatry, University of California at San Diego, La Jolla, CA 92093, U.S.A"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Psychiatry, University of California at San Diego, La Jolla, CA 92093, U.S.A","institution_ids":["https://openalex.org/I36258959"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5022528712"],"corresponding_institution_ids":["https://openalex.org/I36258959"],"apc_list":{"value":3230,"currency":"USD","value_usd":3230},"apc_paid":null,"fwci":1.4965,"has_fulltext":false,"cited_by_count":88,"citation_normalized_percentile":{"value":0.80427177,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":95},"biblio":{"volume":"156","issue":"3","first_page":"375","last_page":"383"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.9940999746322632,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.9940999746322632,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":0.00430000014603138,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10448","display_name":"Memory and Neural Mechanisms","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/2805","display_name":"Cognitive Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/5-ht1a-receptor","display_name":"5-HT1A receptor","score":0.9200000166893005},{"id":"https://openalex.org/keywords/serotonin","display_name":"serotonin","score":0.5299999713897705},{"id":"https://openalex.org/keywords/8-oh-dpat","display_name":"8-OH-DPAT","score":0.9100000262260437},{"id":"https://openalex.org/keywords/buspirone","display_name":"buspirone","score":0.9110000133514404},{"id":"https://openalex.org/keywords/gepirone","display_name":"gepirone","score":0.921999990940094},{"id":"https://openalex.org/keywords/ipsapirone","display_name":"ipsapirone","score":1.0},{"id":"https://openalex.org/keywords/methysergide","display_name":"methysergide","score":0.9890000224113464},{"id":"https://openalex.org/keywords/anxiolytic-effects","display_name":"anxiolytic effects","score":0.6510000228881836},{"id":"https://openalex.org/keywords/fear-conditioning","display_name":"fear conditioning","score":0.37599998712539673},{"id":"https://openalex.org/keywords/acoustic-startle-response","display_name":"acoustic startle response","score":0.6150000095367432}],"concepts":[{"id":"https://openalex.org/C2777287423","wikidata":"https://www.wikidata.org/wiki/Q412194","display_name":"Buspirone","level":4,"score":0.9007693529129028},{"id":"https://openalex.org/C2778362415","wikidata":"https://www.wikidata.org/wiki/Q6065448","display_name":"Ipsapirone","level":5,"score":0.8046268224716187},{"id":"https://openalex.org/C2777845764","wikidata":"https://www.wikidata.org/wiki/Q430986","display_name":"Startle response","level":2,"score":0.622758686542511},{"id":"https://openalex.org/C2781005078","wikidata":"https://www.wikidata.org/wiki/Q424442","display_name":"Methysergide","level":4,"score":0.5526882410049438},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.5439796447753906},{"id":"https://openalex.org/C2776238416","wikidata":"https://www.wikidata.org/wiki/Q4644282","display_name":"8-OH-DPAT","level":5,"score":0.5355852246284485},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5032925009727478},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4950524866580963},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.4494365453720093},{"id":"https://openalex.org/C2781093953","wikidata":"https://www.wikidata.org/wiki/Q21115043","display_name":"5-HT1A receptor","level":5,"score":0.43803805112838745},{"id":"https://openalex.org/C2777765862","wikidata":"https://www.wikidata.org/wiki/Q62903","display_name":"Anxiolytic","level":3,"score":0.43643438816070557},{"id":"https://openalex.org/C58732023","wikidata":"https://www.wikidata.org/wiki/Q770260","display_name":"Partial agonist","level":4,"score":0.4354703426361084},{"id":"https://openalex.org/C137431309","wikidata":"https://www.wikidata.org/wiki/Q1383576","display_name":"Moro reflex","level":3,"score":0.43063342571258545},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4286280870437622},{"id":"https://openalex.org/C23332255","wikidata":"https://www.wikidata.org/wiki/Q5439297","display_name":"Fear-potentiated startle","level":4,"score":0.4242994785308838},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.4239037334918976},{"id":"https://openalex.org/C2776885963","wikidata":"https://www.wikidata.org/wiki/Q245204","display_name":"Antagonist","level":3,"score":0.4151838719844818},{"id":"https://openalex.org/C2775864247","wikidata":"https://www.wikidata.org/wiki/Q167934","display_name":"Serotonin","level":3,"score":0.39202699065208435},{"id":"https://openalex.org/C53910766","wikidata":"https://www.wikidata.org/wiki/Q238516","display_name":"5-HT receptor","level":4,"score":0.33656203746795654},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.23395392298698425},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.22848719358444214},{"id":"https://openalex.org/C558461103","wikidata":"https://www.wikidata.org/wiki/Q154430","display_name":"Anxiety","level":2,"score":0.17479169368743896},{"id":"https://openalex.org/C16837860","wikidata":"https://www.wikidata.org/wiki/Q2079841","display_name":"Fear conditioning","level":3,"score":0.13765299320220947},{"id":"https://openalex.org/C83974742","wikidata":"https://www.wikidata.org/wiki/Q179405","display_name":"Reflex","level":2,"score":0.1016760766506195},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.06116938591003418}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002065","descriptor_name":"Buspirone","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008784","descriptor_name":"Methysergide","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D009281","descriptor_name":"Naphthalenes","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D010879","descriptor_name":"Piperazines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D011743","descriptor_name":"Pyrimidines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D011919","descriptor_name":"Rats, Inbred Strains","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011985","descriptor_name":"Receptors, Serotonin","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D011985","descriptor_name":"Receptors, Serotonin","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D013216","descriptor_name":"Reflex, Startle","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D013216","descriptor_name":"Reflex, Startle","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D013764","descriptor_name":"Tetrahydronaphthalenes","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D017371","descriptor_name":"8-Hydroxy-2-(di-n-propylamino)tetralin","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1016/0014-2999(88)90283-x","doi":"https://doi.org/10.1016/0014-2999(88)90283-x","is_oa":false,"landing_page_url":"https://doi.org/10.1016/0014-2999(88)90283-x","pdf_url":null,"source":{"id":"https://openalex.org/S187816532","display_name":"European Journal of Pharmacology","issn_l":"0014-2999","issn":["0014-2999","1879-0712"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Journal of Pharmacology","raw_type":"journal-article"},{"id":"pmid:2975225","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/2975225","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European journal of pharmacology","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.8048999905586243,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G4741291787","display_name":"HIPPOCAMPAL TRANSMITTER EFFICACY AFTER ANTIDEPRESSANTS","funder_award_id":"R01MH037954","funder_id":"https://openalex.org/F4320337346","funder_display_name":"National Institute of Mental Health"},{"id":"https://openalex.org/G8860252604","display_name":"LIMBIC MONOAMINES, BEHAVIOR, &PSYCHOPATHOLOGY","funder_award_id":"K02MH000188","funder_id":"https://openalex.org/F4320337346","funder_display_name":"National Institute of Mental Health"}],"funders":[{"id":"https://openalex.org/F4320307765","display_name":"Pfizer","ror":"https://ror.org/01xdqrp08"},{"id":"https://openalex.org/F4320337346","display_name":"National Institute of Mental Health","ror":"https://ror.org/04xeg9z08"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":44,"referenced_works":["https://openalex.org/W102964479","https://openalex.org/W1561253511","https://openalex.org/W1886394468","https://openalex.org/W1929995708","https://openalex.org/W1938075917","https://openalex.org/W1970140907","https://openalex.org/W1981818755","https://openalex.org/W1984470666","https://openalex.org/W1986498233","https://openalex.org/W1988695831","https://openalex.org/W1989314580","https://openalex.org/W1990283173","https://openalex.org/W1995977418","https://openalex.org/W2002601777","https://openalex.org/W2013600778","https://openalex.org/W2015340606","https://openalex.org/W2018081910","https://openalex.org/W2030929730","https://openalex.org/W2033628705","https://openalex.org/W2038582232","https://openalex.org/W2041457090","https://openalex.org/W2043205243","https://openalex.org/W2044137171","https://openalex.org/W2045518055","https://openalex.org/W2046994328","https://openalex.org/W2053784771","https://openalex.org/W2057561126","https://openalex.org/W2062132794","https://openalex.org/W2063115509","https://openalex.org/W2064299379","https://openalex.org/W2072387868","https://openalex.org/W2075090213","https://openalex.org/W2083916652","https://openalex.org/W2086052014","https://openalex.org/W2086370837","https://openalex.org/W2090807272","https://openalex.org/W2092456347","https://openalex.org/W2095159956","https://openalex.org/W2104688153","https://openalex.org/W2406417215","https://openalex.org/W2415070581","https://openalex.org/W2418309813","https://openalex.org/W2883849285","https://openalex.org/W4300748935"],"related_works":["https://openalex.org/W2015340606","https://openalex.org/W1991818238","https://openalex.org/W2005853569","https://openalex.org/W2006231318","https://openalex.org/W2084038401","https://openalex.org/W2057377147","https://openalex.org/W2261115999","https://openalex.org/W1998259655","https://openalex.org/W2016344043","https://openalex.org/W2014371004"],"abstract_inverted_index":null,"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1978614486","counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":2},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
